You might be interested in
Health & Biotech
Digital prescription: ASX stocks transforming healthcare sector
Health & Biotech
Dr Boreham's Crucible: Can this Aussie medtech rise as it lifts a cumbersome NHS into the digital age?
Health & Biotech
Shares in medtech small cap Alcidion (ASX:ALC) have risen 15 per cent this morning on news it will provide its data and software services to private Australian healthcare provider Healthscope.
The company aims to “transform healthcare with smart, intuitive technology solutions” that meet the needs of hospital and allied healthcare, and it is active across the globe.
Its shares have been on a tear this calendar year, up around 410 per cent thanks to a series of contract wins in Australia and the UK, as well as improved financial figures. They hit new highs of 23.5c in early Tuesday trade.
Its latest deal, a three-year agreement with Healthscope worth $895,000, will see the two companies collaborate to support Healthscope’s vision for using data to drive transformation in the way healthcare is managed and delivered.
Using data from Healthscope’s 43 hospitals, Alcidion will develop online dashboards to support predictive analytics and help planning for Healthscope services.
Alcidion managing director Kate Quirk recently told Stockhead the healthcare industry is “ready for a real change in the way in which healthcare is delivered and digitialisation is going to be a significant part of that”.
NOW WATCH: 90 Seconds With… Kate Quirke, Alcidion Group Limited
“This is Alcidion’s first implementation of our data analytics capabilities into a private hospital group,” Quirk told shareholders on Tuesday.
“It demonstrates how important data is becoming across the healthcare sector.”
Healthscope owns 43 private hospitals in Australia and pathology operations across New Zealand. It has a team of 18,000 people and 17,500 accredited medical practitioners, providing care to patients ranging from pathology tests to complex surgery.
Read more:
What’s next for e-health play Alcidion after buying MKM Health
Hospital software developer Alcidion scrubs up well after recent buys
iCollege (ASX:ICT) teams with Cambridge University. ICT shares rose 9 per cent to 7.3c on news the company had been chosen as the preferred partner to promote, sell and administer Linguaskill English tests in Australia by Cambridge Assessment English, a division of the esteemed Cambridge University.
Applydirect (ASX:AD1) shares fly 24 per cent. Its fully owned subsidiary Utility Software Services has signed an agreement to provide iGENO, an embedded networks operator, with a comprehensive managed services solution for its customer service operations including the use of its SaaS platform.
KNeoMedia (ASX:KNM) enjoying sales in the US. The edtech company reported “ongoing strong sales momentum” as the US school year kicks off. “Particularly noteworthy is the KneoWorld technology is now achieving broad appeal in the US general education market, which encompasses over ~23 million elementary school students so there is now considerable scope for KneoWorld’s sales to scale-up significantly”, it said.